Section 4135(a) and (b) of the CAA, 2023, titled Access to Non-Opioid Treatments for Pain Relief, amended section 1833(t)(16) and section 1833(i) of the Social Security Act, respectively, to provide for temporary additional payments for non-opioid treatments for pain relief (as that term is defined in section 1833(t)(16)(G)(i) of the Act)
The pharmacy I use issues a certificate of analysis with every batch
Other : Preliminary research suggests benefits for glucose regulation, inflammation reduction, and neuroprotection
Estradiol levels in breastfeeding mothers receiving hormone therapy
It is resistant to stomach acid and, as such, can be administered in water or in food
References & Clinical Resources FDA Pharmacy Compounding Advisory Committee Meeting Agenda (July 2026) FDA Safety Alerts on Compounded Bulk Drug Substances World Anti-Doping Agency (WADA) Prohibited List: Category S2 (Peptide Hormones and Growth Factors) Medical Disclaimer: This article is for general educational purposes only
